Trial Profile
Clinical Evaluation of Alvimopan (SB767905) on Constipation and Related Symptoms Associated With Opioid -A Placebo-Controlled Double-Blind Study in Cancer Patients-
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 13 Dec 2023
Price :
$35
*
At a glance
- Drugs Alvimopan (Primary)
- Indications Constipation
- Focus Therapeutic Use
- Sponsors Cubist Pharmaceuticals; GlaxoSmithKline
- 01 Sep 2015 Status changed from completed to discontinued as per ClinicalTrials.gov record.
- 21 Dec 2011 New trial record